Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Who can get to the bottom of things?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by amillionorbuston Dec 14, 2022 10:54am
164 Views
Post# 35170832

RE:Who can get to the bottom of things?

RE:Who can get to the bottom of things?I've been paying very little attention to BTI for the last few years and only stop in here occasionally to see what's happening. I lightened my load of BTI shares  considerably and pursued other stocks with mostly decent success. I'm glad I did. I feel genuinely sorry for the longs. I haven't done a deep dive on how this deal was put together but JD sums it up pretty good and the market obviously hates it. What a waste of close to 15 years this has been. Sorry to say this but I predict the shorts get a hold of the ticker when it hits the Nasdaq and short it into oblivion like every other small cap stock that needs to do raises to stay afloat. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities